Serving To Educate Primary Care Clinicians On Respiratory Issues
Evidence Based Medicine Header 1
Medical Education Header 2
Peer-to-peer Exchange Header 3
Metabolic Diseases Header 4
News: Articles from our Partners at Consultant 360 November 2019

New Respiratory Disease Articles from our Partners at Consultant 360

Vitamin E Acetate May Be Behind Vaping Injury Outbreak

http://bit.ly/2WjisGE

The Centers for Disease Control and Prevention have released a new report detailing data from Utah that points toward tetrahydrocannabinol-containing vaping cartridges containing vitamin E acetate as the potential cause of the vaping-related lung injury outbreak.

CDC Updates Guidance For Evaluation of Vaping-Related Lung Injury

http://bit.ly/2paBjYv

The Centers for Disease Control and Prevention has updated its interim guidelines on the evaluation and treatment of patients with suspected vaping-related lung injury.

Lung Function Decline Persists Decades After Smoking Cessation

http://bit.ly/2Wj5s3X

The results of a recent study challenge the assumption that lung function begins to normalize soon after smoking cessation.

Sudden Changes in Inhaled Corticosteroid Formulary Greatly Impact Children

http://bit.ly/2Wjr1kR

The type of ICS a child with asthma receives is often dictated by the formulary that insurance covers. Authors of a study presented at CHEST 2019 determined the impact of a sudden change in insurance formulary coverage on lung function in pediatric asthma.

New Inhaler Medication May Reduce COPD Exacerbation Rates With No Effect on CV Risk

http://bit.ly/2qSZMSz

Researchers performed a subgroup analysis of the ASCENT-COPD trial to study the effects of aclidinium bromide on cardiovascular safety and COPD exacerbation rates.